Home » Newsletters » BioWorld Asia

BioWorld Asia

April 1, 1998

View Archived Issues

TAb Attempting To Bolster Finances With £20M Offering

Role Of Cytotoxic T Cells Discovered In Controlling HIV

French Officials Back Formation Of Biotechnology Seed Fund

Europe Considering Guidelines For Gene Therapy Products

D-Pharm Receives Patent In US For Epilepsy Drug

Phytopharm Seeks Partners For Eczema Botanical Product

Transgène Sells More Shares At Higher Price Than Expected

Ribotargets, MSI In Pact For RNA-Based Drug Design

Wealthy Australian Wants To Back Human Cloning Efforts

Australian Researchers Discover Key Malaria Gene

French Scientists Develop More Accurate Gene Therapy Targeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...